Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Deferred Taxes (2016 - 2020)

Historic Deferred Taxes for Cumberland Pharmaceuticals (CPIX) over the last 9 years, with Q4 2020 value amounting to $21802.0.

  • Cumberland Pharmaceuticals' Deferred Taxes changed 0.46% to $21802.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $21802.0, marking a year-over-year decrease of 6666.77%. This contributed to the annual value of $21802.0 for FY2020, which is 6666.77% down from last year.
  • Latest data reveals that Cumberland Pharmaceuticals reported Deferred Taxes of $21802.0 as of Q4 2020, which was down 0.46% from $21803.0 recorded in Q4 2019.
  • Cumberland Pharmaceuticals' 5-year Deferred Taxes high stood at $3.5 million for Q2 2017, and its period low was -$87210.0 during Q4 2017.
  • For the 5-year period, Cumberland Pharmaceuticals' Deferred Taxes averaged around $454129.9, with its median value being $81886.0 (2018).
  • Data for Cumberland Pharmaceuticals' Deferred Taxes shows a peak YoY increase of 129448.14% (in 2016) and a maximum YoY decrease of 10966.06% (in 2016) over the last 5 years.
  • Quarter analysis of 5 years shows Cumberland Pharmaceuticals' Deferred Taxes stood at -$43109.0 in 2016, then tumbled by 102.3% to -$87210.0 in 2017, then surged by 193.9% to $81886.0 in 2018, then tumbled by 73.37% to $21803.0 in 2019, then dropped by 0.0% to $21802.0 in 2020.
  • Its Deferred Taxes stands at $21802.0 for Q4 2020, versus $21803.0 for Q4 2019 and $43605.0 for Q1 2019.